Clinical Trials and Mechanistic Clinical Studies to Advance Adjunctive Therapies for Glucometabolic Control in Type 1 Diabetes



Topic: Diabetes.

Destination: JDRF is committed to accelerating the development of therapies that can complement insulin (i.e., adjunctive therapies) to improve glucose and metabolic outcomes in people with type 1 diabetes (T1D). To this end, they invite applications that propose (1) clinical trials to evaluate glucometabolic therapies in people with T1D or (2) mechanistic clinical studies to advance our knowledge of glucometabolic control in T1D toward the goal of future therapy development.

Budget: $1,000,000-2,000,000.

Duration: 2-3 years.


Are you interested in this call?

Estàs interessat?

Omple el següent formulari per rebre més informació: